A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obinutuzumab or Placebo in Combination with Mycophenolate Mofetil in Patients with Active Class III or IV Lupus Nephritis

被引：0

作者：

Furie, Richard ^{[1
]}

Aroca, Gustavo ^{[2
,3
]}

Alvarez, Analia ^{[4
]}

Fragoso-Loyo, Hilda ^{[5
]}

Zuta Santillan, Elizabeth ^{[6
]}

Rovin, Brad ^{[7
]}

Schindler, Thomas ^{[8
]}

Hassan, Imran ^{[9
]}

Cascino, Matthew ^{[10
]}

Garg, Jay P. ^{[11
]}

Malvar, Ana ^{[12
]}

机构：

[1] Northwell Hlth, Great Neck, NY USA

[2] Simon Bolivar Univ, Barranquilla, Colombia

[3] Clin Costa, Barranquilla, Colombia

[4] CEMIC, Buenos Aires, DF, Argentina

[5] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico

[6] Inst Ginecol & Reprod, Lima, Peru

[7] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

[8] F Hoffmann La Roche & Cie AG, Basel, Switzerland

[9] Hoffmann La Roche Ltd, Mississauga, ON, Canada

[10] Genentech Inc, San Francisco, CA USA

[11] Genentech Inc, San Francisco, CA 94080 USA

[12] Hosp Fernandez, Org Maed Invest, Buenos Aires, DF, Argentina

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0939

引用

页数：3

共 50 条

[41] Randomized double-blind placebo-controlled trial to evaluate efficacy and safety of prucalopride (Resolor®) in elderly patients with chronic
Mueller-Lissner, Stefan A.
Rykx, An
Kerstens, Rene
Vandeplassche, Lieve
GASTROENTEROLOGY, 2008, 134 (04) : A157 - A157
[42] A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
Rovin, Brad H.
Solomons, Neil
Pendergraft, William F., III
Dooley, Mary Anne
Tumlin, James
Romero-Diaz, Juanita
Lysenko, Lidia
Navarra, Sandra V.
Huizinga, Robert B.
KIDNEY INTERNATIONAL, 2019, 95 (01) : 219 - 231
[43] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
Croop, R.
Lipton, R. B.
Kudrow, D.
Stock, D. A.
Kamen, L.
Conway, C. M.
Stock, E. G.
Coric, V.
Goadsby, P. J.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29
[44] A phase 2/3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rimegepant for the preventive treatment of migraine
Croop, R.
Lipton, R. B.
Kudrow, D.
Stock, D. A.
Kamen, L.
Conway, C. M.
Stock, E. G.
Coric, V
Goadsby, P. J.
HEADACHE, 2021, 61 : 98 - 99
[45] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
Croop, Robert
Lipton, Richard
Thiry, Alexandra
Kamen, Lisa
Coric, Vlad
Goadsby, Peter
NEUROLOGY, 2021, 96 (15)
[46] A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine
Sun, H.
Silberstein, S.
Dodick, D. W.
Reuter, U.
Ashina, M.
Saper, J. R.
Cady, R.
Chon, Y.
Dietrich, J.
Lenz, R.
HEADACHE, 2015, 55 : 132 - 132
[47] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
Croop, R.
Lipton, R. B.
Kudrow, D.
Stock, D. A.
Kamen, L.
Conway, C. M.
Stock, E. G.
Coric, V.
Goadsby, P. J.
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 19 - 19
[48] Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
Hobbs, Kathryn
Deodhar, Atul
Wang, Brian
Bitman, Bojena
Nussbaum, Joyce
Chung, James
Collier, David H.
SPRINGERPLUS, 2015, 4 : 1 - 7
[49] A double-blind randomized placebo-controlled clinical study to evaluate the efficacy and safety of a polyherbal formulation in geriatric age group: A phase IV clinical report
Banerjee, Payel
Maity, Soumya
Das, Tapas
Mazumder, Santasree
JOURNAL OF ETHNOPHARMACOLOGY, 2011, 134 (02) : 429 - 433
[50] Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
Mollace, Rocco
Gliozzi, Micaela
Macri, Roberta
Tavernese, Annamaria
Musolino, Vincenzo
Carresi, Cristina
Maiuolo, Jessica
Muscoli, Carolina
Tomino, Carlo
Rosano, Giuseppe Maria
Fini, Massimo
Volterrani, Maurizio
Silvestrini, Bruno
Mollace, Vincenzo
PHARMACEUTICS, 2022, 14 (01)

← 1 2 3 4 5 →